Table 3.
Multivariate prognostic analysis after propensity score matching.
| Variables | BCSS | OS | ||||
|---|---|---|---|---|---|---|
| HR | 95%CI | P | HR | 95%CI | P | |
| Age (years) | ||||||
| 70-74 | 1 | 1 | ||||
| 75-79 | 1.539 | 1.536-1.164 | 0.002 | 1.600 | 1.449-1.767 | <0.001 |
| 80-84 | 1.859 | 1.420-2.427 | <0.001 | 2.436 | 2.218-2.675 | <0.001 |
| ≥85 | 3.138 | 2.363-4.166 | <0.001 | 4.223 | 3.819-4.669 | <0.001 |
| Race | ||||||
| Non-Hispanic White | 1 | 1 | ||||
| Non-Hispanic Black | 0.966 | 0.657-1.419 | 0.859 | 1.008 | 0.883-1.152 | 0.901 |
| Hispanic (All Races) | 0.925 | 0.630-1.359 | 0.692 | 0.897 | 0.785-1.026 | 0.113 |
| Other | 0.589 | 0.357-0.973 | 0.039 | 0.680 | 0.580-0.796 | <0.001 |
| Histology | ||||||
| Invasive ductal carcinoma | 1 | 1 | ||||
| Invasive lobular carcinoma | 1.184 | 0.886-1.583 | 0.253 | 1.010 | 0.908-1.122 | 0.861 |
| Other | 0.894 | 0.620-1.289 | 0.548 | 1.072 | 0.962-1.195 | 0.209 |
| Grade | ||||||
| Well differentiated | 1 | 1 | ||||
| Moderately differentiated | 1.298 | 1.041-1.618 | 0.020 | 1.063 | 0.994-1.137 | 0.076 |
| Poorly/undifferentiated | 2.903 | 2.227-3.785 | <0.001 | 1.378 | 1.243-1.527 | <0.001 |
| Tumor stage | ||||||
| T1 | 1 | 1 | ||||
| T2 | 2.772 | 2.271-3.385 | <0.001 | 1.581 | 1.462-1.710 | <0.001 |
| PR status | ||||||
| Negative | 1 | 1 | ||||
| Positve | 0.642 | 0.506-0.815 | <0.001 | 0.942 | 0.855-1.036 | 0.218 |
| Chemotherapy | ||||||
| No | 1 | 1 | ||||
| Yes | 1.180 | 0.689-2.018 | 0.547 | 0.822 | 0.619-1.092 | 0.176 |
| RT | ||||||
| No | 1 | 1 | ||||
| Yes | 0.562 | 0.506-0.815 | <0.001 | 0.612 | 0.575-0.652 | <0.001 |